Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Device
Medical Devices/Diagnostic Equipment

Impedimed Limited: SOZO Bilateral Arm L-Dex Software Recalled for Reduced Sensitivity

Agency Publication Date: October 24, 2023
Share:
Sign in to monitor this recall

Summary

Impedimed Limited is recalling 354 units of its SOZO Bilateral Arm L-Dex Software, specifically versions 4.1 and 5.0. The software used for bilateral arm assessments does not have the same level of sensitivity as the unilateral (one-arm) version when trying to detect early signs of lymphedema. This software defect could cause doctors to miss early warning signs of the condition, leading to delayed medical intervention and potentially requiring more aggressive treatment later on. These software versions were distributed across 40 U.S. states and the District of Columbia.

Risk

The software may fail to accurately flag early lymphedema symptoms during bilateral assessments. This under-recognition can delay critical early-stage treatment, allowing the condition to progress to a point where more invasive or aggressive medical procedures are necessary.

What You Should Do

  1. Check your SOZO system software version to see if you are running version 4.1 or 5.0 with UDI-DI: B277SFT0250.
  2. If your facility uses this software for lymphedema screening, contact your healthcare provider or medical director to discuss the potential for under-recognition of early symptoms in patients who received bilateral assessments.
  3. Contact Impedimed Limited directly to receive instructions on software updates or patches that may address this sensitivity issue.
  4. Patients who have undergone assessments using this software should consult their healthcare provider to determine if a re-evaluation using alternative methods or the unilateral assessment is necessary.
  5. For further questions or technical support, contact the FDA's medical device division at 1-888-463-6332 or visit www.fda.gov/medical-devices/medical-device-recalls.

Your Remedy Options

๐Ÿ“‹Other Action

Manufacturer Notification and Guidance

How to: Contact your healthcare provider or the manufacturer for further instructions and potential refund

Affected Products

Product: SOZO Bilateral Arm L-Dex Software (Software v4.1 and v5.0)
Model / REF:
Software v4.1
Software v5.0
Lot Numbers:
UDI-DI: B277SFT0250

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 92943
Status: Active
Manufacturer: Impedimed Limited
Sold By: Medical facilities; Hospitals; Specialty clinics
Manufactured In: Australia
Units Affected: 354
Distributed To: Iowa, California, Illinois, Alaska, New York, Florida, Kansas, Wisconsin, Michigan, North Carolina, Georgia, South Dakota, Kentucky, Texas, Massachusetts, Louisiana, Arizona, Rhode Island, Arkansas, Colorado, Wyoming, Ohio, Indiana, Missouri, New Jersey, Maryland, Connecticut, Washington, Pennsylvania, Utah, Virginia, New Mexico, Maine, Minnesota, District of Columbia, Tennessee, Nebraska, Oregon, North Dakota, West Virginia

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.